The content on this site is intended for healthcare professionals only
Dr Amy Abernethy talks to ecancer at the 2013 WIN Symposium in Paris about the challenges that occur in translational research when the jump is made between the lab and the clinic.
Clinical decision support tools centers on matching information learned in the lab to the care of the patient. Dr Abernethy discusses how to quickly integrate new and sophisticated information to make decisions regarding patient care.
Filmed in Partnership with the WIN Consortium
Daratumumab, bortezomib/thalidomide/dexamethasone (D-VTd) and DARA maintenance shows benefit in transplant-eligible NDMM
Revolutionising myeloma treatment through immune profiling
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Amivantamab-lazertinib continue to show benefit as a first-line standard-of-care for EGFR-mutated advanced NSCLC
ESMO 2024: Highlights and analysis
Understanding the use of PARPi combinations to treat patients with mCRPC
